Chemed Corp. (CHE) Tops Q3 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $511.37 -0.91%
EPS Growth %: +22.2%
Financial Fact:
Income taxes: -16.66M
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +22.2%
Financial Fact:
Income taxes: -16.66M
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Chemed Corp. (NYSE: CHE) reported Q3 EPS of $1.78, $0.17 better than the analyst estimate of $1.61. Revenue for the quarter came in at $386 million versus the consensus estimate of $375.95 million.
Chemed Corp. sees FY2015 EPS of $6.75-$6.80, versus the consensus of $6.75.
For earnings history and earnings-related data on Chemed Corp. (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Medpace beats Q3 estimates but guides below on revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
